Ar­genx de­buts first DTC for myas­the­nia gravis med Vyv­gart even as MG com­mu­ni­ty ef­fort con­tin­ues

4 years ago
Pharma
Marketing

Covid vac­cine mak­ers Pfiz­er, J&J notch high brand marks amid over­all still-strong phar­ma in­dus­try rep: Har­ris Poll

4 years ago
Pharma
Marketing

Ten months af­ter dev­as­tat­ing fail­ure, Roche says it sees path for­ward for Hunt­ing­ton’s drug

4 years ago
R&D

Lat­est news on Pfiz­er's $3B+ JAK1 win; Pacts over M&A at #JPM22; 2021 by the num­bers; Bio­gen's Aduhelm reck­on­ing; The ...

4 years ago
Weekly

A $3B+ peak sales win? Pfiz­er thinks so, as FDA of­fers a tardy green light to its JAK1 drug abroc­i­tinib

4 years ago
Pharma
FDA+

Vir ex­pands part­ner­ship with Gates Foun­da­tion, adding $50M for HIV and malar­ia an­ti­body re­search ini­tia­tive

4 years ago
Deals

Bio­phar­ma deal­mak­ers re­flect on last year's shifts in the mar­ket, as they gear up for an­oth­er 'ac­tive' year ahead

4 years ago
Deals

Eu­rope preps for the launch of its new clin­i­cal tri­als data­base, with a push to in­crease tri­al par­tic­i­pa­tion

4 years ago
FDA+

Fol­low­ing a tu­mul­tuous year, Emer­gen­t's founder will re­tire in April

4 years ago
Manufacturing

Af­ter nab­bing two AI-gen­er­at­ed mol­e­cules, As­traZeneca re­turns to Benev­o­len­tAI with new col­lab­o­ra­tion

4 years ago
Deals
AI

#JPM22: High­lights for the year ahead in on­col­o­gy R&D — What's hot, what's not?

4 years ago
R&D

#JPM22 - The gene edit­ing rev­o­lu­tion: Now it's time for hu­man da­ta to de­fine a fast-chang­ing field

4 years ago
R&D

Covid-19 roundup: Supreme Court blocks Biden ad­min­is­tra­tion's vac­cine man­date for large busi­ness­es; South Africa ...

4 years ago
Coronavirus

Rob Califf ad­vances as Biden's FDA nom­i­nee, with a close com­mit­tee vote

4 years ago
FDA+

Er­ic Os­tertag reach­ing the end of the line as Po­sei­da chief, will be­come ex­ec­u­tive chair­man; Alec­tor ex­ec named CEO ...

4 years ago
Peer Review

Ex­clu­sive: Bio­gen lead­ers warn sales teams: On­ly 2,000 pa­tients might ac­cess Aduhelm over the next sev­er­al years

4 years ago
Pharma

Trail­blaz­ing can­cer re­searcher Beat­rice Mintz dies at 100 years old

4 years ago
People

#JPM22 - Deal­mak­ing in 2022: What's Big Phar­ma look­ing for and what is it will­ing to pay?

4 years ago
Deals

#JPM22: The fire­side chat with Take­da CEO Christophe We­ber

4 years ago
Marketing

Covid-19 man­u­fac­tur­ing roundup: NY biotech primed to be­come Im­mu­ni­ty­Bio's drug sub­stance gold­mine; Illi­nois set to ...

4 years ago
R&D

FDA con­cerns at con­trac­tor Catal­ent site spurred on short­ages of No­vo Nordisk's semaglu­tide — re­port

4 years ago
Manufacturing

Largest Catal­ent site will ex­pand cold chain of­fer­ings; First phase com­plet­ed for Avid's CA up­grade 

4 years ago
Manufacturing

Pfiz­er says it's ready to ramp up Paxlovid pro­duc­tion. Ex­perts say it's not that easy

4 years ago
Manufacturing

Twit­ter aims to bring med­ical con­fer­ences — and ad spon­sors — from ‘in­side 4 walls and 3 days’ to dig­i­tal ...

4 years ago
Pharma
Marketing
First page Previous page 598599600601602603604 Next page Last page
A service from the Financial Times